AXIS 2: AX200 for the Treatment of Ischemic Stroke (AXIS-2)
AXIS 2: AX200 for the Treatment of Ischemic Stroke - A Multinational, Multicenter, Randomized, Doubleblind, Placebo-controlled Phase II Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Linz, Austria, 4020
- Landes-Nervenklinik Wagner-Jauregg
-
Linz, Austria, 4021
- AHK Linz
-
Wien, Austria, 1160
- Wilhelminenspital
-
-
-
-
-
Brugge, Belgium, 8000
- AZ Sint-Jan AV
-
Bruxelles, Belgium, 1200
- Cliniques universitaires Saint-Luc
-
Gent, Belgium, 9000
- Universitair Ziekenhuis Gent
-
Leuven, Belgium, 3000
- UZ Gasthuisberg
-
-
-
-
-
Brno, Czech Republic, 656 91
- St. Anne's Faculty Hospital
-
Olomouc, Czech Republic, 775 20
- Faculty Hospital
-
Ostrava, Czech Republic, 708 52
- Faculty Hospital Ostrava
-
Ostrava, Czech Republic, 728 80
- Municipal Hospital Ostrava
-
Plzeň - Lochotín, Czech Republic, 304 60
- Faculty Hospital 1
-
Praha, Czech Republic, 120 00
- General Faculty Hospital
-
Praha, Czech Republic, 150 06
- Faculty Hospital Motol
-
-
-
-
-
Aachen, Germany, 52074
- Universitatsklinikum der RWTH Aachen
-
Altenburg, Germany, 04600
- Kreiskrankenhaus Altenburg gGmbH
-
Berlin, Germany, 10117
- Charité Universitätsmedizin Berlin
-
Berlin, Germany, 12200
- Charite Universitätsklinikum "Benjamin Franklin" Klinik und Poliklinik für Neurologie
-
Bielefeld, Germany, 33617
- Evangelisches Krankenhaus Bielefeld
-
Bremen, Germany, 28177
- Klinikum Bremen-Mitte gGmbH
-
Chemnitz, Germany, 09131
- Klinik für Neurologie Chemnitz
-
Düsseldorf, Germany, 40479
- Marienhospital Düsseldorf
-
Erlangen, Germany, 91054
- Universität Erlangen-Nurnberg
-
Essen, Germany, 45122
- Universitätsklinikum Essen
-
Freiburg, Germany, 79106
- Neurologische Universitätsklinik Freiburg
-
Halle (Saale), Germany, 06112
- Berufsgenossenschaftliche Kliniken Bergmannstrost
-
Hamburg, Germany, 20246
- Universitätsklinik Hamburg Eppendorf
-
Heidelberg, Germany, 69120
- Universität Heidelberg
-
Jena, Germany, 07747
- Friedrich-Schiller-Universitätsklinikum
-
Leipzig, Germany, 04103
- Universitatsklinikum Leipzig
-
Ludwigshafen, Germany, 67063
- Klinikum der Stadt Ludwigshafen
-
Marburg, Germany, 35039
- Philipps-Universität Marburg
-
München, Germany, 81675
- Technische Universität München Klinikum rechts der Isar
-
Münster, Germany, 48149
- Universitätsklinikum Münster
-
Osnabrück, Germany, 49076
- Klinikum Osnabrück GmbH
-
Teupitz, Germany, 15755
- ASKLEPIOS Fachklinikum Teupitz
-
Tübingen, Germany, 72076
- Neurologische Klinik, Eberhard-Karls-Universität Tübingen
-
Ulm, Germany, 89081
- Universitätsklinikum Ulm
-
-
-
-
-
Białystok, Poland, 15-276
- Klinika Neurologii z Pododdziałem Udarowym
-
Gdańsk, Poland, 80-803
- Wojewódzki Szpital Specjalistyczny im. Mikołaja Kopernika w Gdańsku, Oddział Neurologiczny i Leczenia Udarów Mózgu
-
Warszawa, Poland, 02-957
- II Klinika Neurologii
-
Warszawa, Poland, 02-957
- Instytut Psychiatrii i Neurologii, I Klinika neurologii
-
Łódź, Poland, 90-549
- Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej Uniwersytetu Medycznego w Łodzi, Centralny Szpital Weteranów, Klinika neurologii i epileptologii z oddziałem udarowym
-
-
-
-
-
Bratislava, Slovakia, 813 69
- Comenius University Bratislava
-
Bratislava, Slovakia, 826 06
- 4. Faculty Hospital with Policlinic
-
Bratislava, Slovakia, 833 05
- Faculty Hospital L. Derer
-
Košice, Slovakia, 041 66
- Faculty Hospital
-
Martin, Slovakia, 036 59
- Faculty Hospital
-
Nitra, Slovakia, 949 01
- Faculty Hospital Nitra
-
Trnava, Slovakia, 917 75
- Fakultna Nemocnica Trnava
-
-
-
-
-
Barcelona, Spain, 08036
- Hospital Clinic de Barcelona
-
Barcelona, Spain, 08025
- Hospital Santa Creu i Sant Pau
-
Girona, Spain, 17017
- Hospital Dr. Josep Trueta
-
Madrid, Spain, 28006
- Hospital de La Princesa
-
Madrid, Spain, 28034
- Hospital Ramon y Cajal / Fundacion para le Investigacion Biomedica del Hospital Ramon y Cajal
-
Madrid, Spain, 28046
- Hopsital Univ. La Paz / Fundacion para la Investigacion
-
Sevilla, Spain, 41013
- Hospital Univ. Virgen del Rocío
-
Valencia, Spain, 46010
- Hospital Clinico Universitario
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Major Inclusion Criteria:
- diagnosis of acute ischemic stroke with an onset within 9 hours prior to start of study agent administration
- ischemic stroke in the MCA territory confirmed by MRI (diffusion)
- age ≥18 years and ≤85 years
- lesion size on DWI ≥15 ccm
- written informed consent
Major Exclusion Criteria:
- prior to current stroke: inability to walk or to lead an independent life
- life expectancy less or equal 6 months
- stupor or coma
- lacunar infarct
- any evidence of ICH
- malignant hypertension
- presence of history of active malignancies
- platelet count <100/nl at randomization
- leukocyte count >20/nl at randomization
- congenital neutropenia
- pregnant or lactating women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Placebo
|
Short term infusion (20 to 30 minutes) and continuous infusion over 3 days
|
|
EXPERIMENTAL: AX200
|
135 μg/kg body weight total dose Short term infusion (20 to 30 minutes) and continuous infusion over 3 days
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improvement on mRS relative to placebo-treated patients
Time Frame: day 90
|
day 90
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improvement on NIHSS relative to placebo-treated patients
Time Frame: day 90
|
day 90
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Frank Rathgeb, Dr., Sygnis Bioscience GmbH & Co KG
- Study Director: Rico Laage, Dr., Sygnis Bioscience GmbH & Co KG
Publications and helpful links
General Publications
- Scheldeman L, Wouters A, Dupont P, Christensen S, Boutitie F, Cheng B, Ebinger M, Endres M, Fiebach JB, Gerloff C, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Ringelstein EB, Chamorro A, Grond M, Laage R, Schneider A, Thomalla G, Thijs V, Lemmens R. Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion. Stroke. 2021 Jul;52(7):2338-2346. doi: 10.1161/STROKEAHA.120.033071. Epub 2021 May 13.
- Bu N, Khlif MS, Lemmens R, Wouters A, Fiebach JB, Chamorro A, Ringelstein EB, Norrving B, Laage R, Grond M, Wilms G, Brodtmann A, Thijs V. Imaging Markers of Brain Frailty and Outcome in Patients With Acute Ischemic Stroke. Stroke. 2021 Mar;52(3):1004-1011. doi: 10.1161/STROKEAHA.120.029841. Epub 2021 Jan 28.
- Kufner A, Wouters A, Bracoud L, Laage R, Schneider A, Schabitz WR, Hermier M, Thijs V, Fiebach JB; AXIS2 investigators. Infarct volume-based subgroup selection in acute ischemic stroke trials. Stroke. 2015 May;46(5):1368-70. doi: 10.1161/STROKEAHA.114.008115. Epub 2015 Mar 12.
- Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, Saver J, Laage R, Schneider A, Rathgeb F, Vogt G, Charisse G, Fiebach JB, Schwab S, Schabitz WR, Kollmar R, Fisher M, Brozman M, Skoloudik D, Gruber F, Serena Leal J, Veltkamp R, Kohrmann M, Berrouschot J; AXIS 2 Investigators. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke. 2013 Oct;44(10):2681-7. doi: 10.1161/STROKEAHA.113.001531. Epub 2013 Aug 20.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Brain Ischemia
- Infarction
- Brain Infarction
- Stroke
- Ischemic Stroke
- Ischemia
- Cerebral Infarction
- Physiological Effects of Drugs
- Immunologic Factors
- Adjuvants, Immunologic
- Lenograstim
Other Study ID Numbers
Other Study ID Numbers
- AX200-101
- EudraCT 2008-006444-19
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.